Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02436408
Title VISmodegib for ORbital and Periocular Basal Cell Carcinoma
Recruitment Completed
Gender both
Phase FDA approved
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

basal cell carcinoma

orbital cancer

Therapies

Vismodegib

Age Groups: adult
Covered Countries USA


No variant requirements are available.